Latest News
MiNK Therapeutics, Inc.
- Mink Therapeutics CEO Buell sells $73,265 in stock for tax obligations
- Form 4 Mink Therapeutics Inc: Jennifer Buell (Director, CEO) For: 11 October
- MiNK Therapeutics (INKT) CEO sells 6,938 shares solely to cover taxes owed upon vesting.
- Form 144 MiNK Therapeutics For: 13 October By Investing.com
- MiNK Therapeutics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (INKT)
- MiNK Therapeutics (INKT) Edges Higher as Shares Hold Above Key Support - Institutional Buy Signals
- Brazil Unlocked: Jennifer S. Buell on Brazil’s Role in Advancing Agenus and MiNK Therapeutics Clinical Programs
- MiNK’s iNKT platform selected for $87M ARPA-H program By Investing.com
- MiNK Therapeutics Selected for ARPA-H Initiative to Develop Room-Temperature Cell Therapy
- MiNK Therapeutics’ agenT-797 Selected for ARPA-H BoSS Program to Advance Room-Temperature Cell Therapy Storage
Headlines from the last 30 days, linking to the original publishers. See all market news →